Clinical Trial Update: Oxaloacetate in Myasthenia Gravis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating oxaloacetate for Myasthenia Gravis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Oxaloacetate (oxaloacetate)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Myasthenia Gravis | Phase 1 | Status: WITHDRAWN